Amgen (AMGN) Income from Continuing Operations (2009 - 2026)

Amgen's Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 1819000000.0 for Q1 2026.

• In Q1 2026, Income from Continuing Operations rose 5.14% year-over-year to 1819000000.0; the TTM figure through Mar 2026 stood at 7800000000.0 (up 31.47% YoY), while the FY2025 annual figure was 7711000000.0, up 88.53% from the prior year.
• Income from Continuing Operations was 1819000000.0 for Q1 2026 at Amgen, up from 1333000000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 3216000000.0 in Q3 2025 to a low of 113000000.0 in Q1 2024.
• Historically, Income from Continuing Operations has averaged 1581705882.35 across 5 years, with a median of 1476000000.0 in 2022.
• The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations plunged 103.98% in 2024, then surged 1630.97% in 2025.
• A 5-year view of Income from Continuing Operations shows it stood at 1616000000.0 in 2022, then slumped by 52.54% to 767000000.0 in 2023, then retreated by 18.25% to 627000000.0 in 2024, then soared by 112.6% to 1333000000.0 in 2025, then surged by 36.46% to 1819000000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 1819000000.0 (Q1 2026), 1333000000.0 (Q4 2025), and 3216000000.0 (Q3 2025), per Business Quant data.